Napigen
Wilmington, US · Founded 2016 · 19 employees on LinkedIn · 1 known investors
Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.
Investors · 1
Competitors · 5
by search overlap
Precigen9 shared keywordsPrecigen is a biopharmaceutical company developing gene and cell therapies, including PAPZIMEOS (zopapogene imadenovec-drba), an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis. The company focuses on immuno-oncology and immunotherapy treatments delivered via subcutaneous injection.
Perigen8 shared keywordsPeriGen develops perinatal software for hospital labor and delivery units, including centralized fetal surveillance, an FDA-cleared machine learning system for fetal heart rate interpretation, and early warning tools that help clinicians identify maternal and fetal risks during childbirth. Its products serve obstetric teams and health systems of all sizes across the United States and Canada.
PepGen5 shared keywordsPepGen develops disease-modifying therapeutics aimed at the underlying causes of serious genetic neuromuscular and neurological diseases. The company is building a pipeline of oligonucleotide-based treatments for these conditions.
NVIGEN4 shared keywordsNVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
Biogen Idec4 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Companies competing with Napigen for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $225K |
| Department of Agriculture (USDA) | Phase I | 2020 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Napigen do?
- Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.
- Who are Napigen's investors?
- Napigen's investors include The Innovation Space.
- Where is Napigen headquartered?
- Napigen is headquartered in Wilmington, US.